Literature DB >> 7855618

The use of monoclonal antibody G250 in the therapy of renal-cell carcinoma.

E Oosterwijk1, F M Debruyne, J A Schalken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7855618

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  2 in total

1.  Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity.

Authors:  Dafei Chai; Dong Qiu; Xiaoqing Shi; Jiage Ding; Nan Jiang; Zichun Zhang; Jiawei Wang; Jie Yang; Pengli Xiao; Gang Wang; Junnian Zheng
Journal:  Mol Ther Oncolytics       Date:  2021-11-29       Impact factor: 7.200

Review 2.  Radiolabeled antibodies in renal cell carcinoma.

Authors:  Alexander B Stillebroer; Egbert Oosterwijk; Wim J G Oyen; Peter F A Mulders; Otto C Boerman
Journal:  Cancer Imaging       Date:  2007-11-19       Impact factor: 3.909
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.